Recovery of microarray-quality RNA from frozen EDTA blood samples.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 19028589)

Published in J Pharmacol Toxicol Methods on November 05, 2008

Authors

Johanna M Beekman1, Joachim Reischl, David Henderson, David Bauer, Rainer Ternes, Carol Peña, Chetan Lathia, Jürgen F Heubach

Author Affiliations

1: Clinical Pharmacology, Bayer Schering Pharma AG, Berlin, Germany. johanna.beekman@bayerhealthcare.com

Articles by these authors

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol (2006) 6.95

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol (2009) 6.86

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol (2009) 2.95

Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors. Clin Cancer Res (2005) 2.76

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study. Circulation (2010) 2.46

Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial. Clin Cancer Res (2010) 2.26

Developing a new, national approach to surveillance for ventilator-associated events*. Crit Care Med (2013) 2.24

A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel. Clin Cancer Res (2008) 1.99

Dysfunction of dysferlin-deficient hearts. J Mol Med (Berl) (2007) 1.89

Developing predictive molecular maps of human disease through community-based modeling. Nat Genet (2012) 1.88

Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (2004) 1.77

Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer. Clin Cancer Res (2006) 1.58

Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol (2006) 1.53

Effect of pressure on the crystal structure of salicylaldoxime-I, and the structure of salicylaldoxime-II at 5.93 GPa. Acta Crystallogr B (2006) 1.45

Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer. Anticancer Drugs (2009) 1.42

MS-275, a potent orally available inhibitor of histone deacetylases--the development of an anticancer agent. Int J Biochem Cell Biol (2007) 1.31

Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors. Clin Cancer Res (2007) 1.26

Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Chest (2013) 1.20

Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies. IEEE Trans Biomed Eng (2014) 1.18

Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. Gastrointest Cancer Res (2011) 1.10

Spatial distribution of transcript changes in the maize primary root elongation zone at low water potential. BMC Plant Biol (2008) 1.09

Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation (2002) 1.07

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging (2011) 1.06

Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke (2011) 1.06

Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancer. Clin Cancer Res (2007) 1.05

Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1. Tetrahedron (2009) 1.04

PhenomicDB: a multi-species genotype/phenotype database for comparative phenomics. Bioinformatics (2004) 1.01

Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res (2005) 0.98

Analyzing the evolution of the opioid/orphanin gene family. Mass Spectrom Rev (2003) 0.97

Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase. J Med Chem (2008) 0.97

Fronto-hippocampal function during temporal context monitoring in schizophrenia. Biol Psychiatry (2006) 0.97

Spongistatin synthetic studies. evolution of a scalable synthesis for the EF fragment of (+)-Spongistatin 1 exploiting a Petasis-Ferrier union/rearrangement tactic. Org Lett (2004) 0.94

Tissue distribution of a human Ca v 1.2 alpha1 subunit splice variant with a 75 bp insertion. Cell Calcium (2005) 0.94

Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors. Bioorg Med Chem Lett (2009) 0.94

Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism. Arch Neurol (2009) 0.93

Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers. J Neuroimmunol (2008) 0.89

S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway. J Pharmacol Exp Ther (2011) 0.89

Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing? Clin Infect Dis (2012) 0.89

Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer. Clin Cancer Res (2007) 0.88

Separable transcriptional regulatory domains within Otd control photoreceptor terminal differentiation events. Dev Biol (2010) 0.88

Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. J Pathol (2014) 0.87

Antibodies that identify only the active conformation of G(i) family G protein alpha subunits. FASEB J (2008) 0.87

Suicide in the medical setting. Jt Comm J Qual Patient Saf (2008) 0.87

Developing a new, national approach to surveillance for ventilator-associated events. Am J Crit Care (2013) 0.87

Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens. J Immunother (2005) 0.87

Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Infect Control Hosp Epidemiol (2013) 0.86

Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies. Invest New Drugs (2005) 0.85

Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis. Mol Biotechnol (2006) 0.85

Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Clin Infect Dis (2013) 0.85

Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study. Cancer Chemother Pharmacol (2011) 0.84

Preclinical evaluation of biomarkers for response monitoring to the MET inhibitor BAY-853474. Biomarkers (2012) 0.84

Integration into the Australian health care system--insights from international medical graduates. Aust Fam Physician (2009) 0.84

Executive summary: Developing a new, national approach to surveillance for ventilator-associated events. Ann Am Thorac Soc (2013) 0.84

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies. J Neuroinflammation (2012) 0.82

Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. CNS Spectr (2005) 0.82

Variations in faculty assessment of NICU flowsheet data: implications for electronic data display. Int J Med Inform (2011) 0.82

Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assays. Melanoma Res (2015) 0.81

Plant-synthesized E. coli CFA/I fimbrial protein protects Caco-2 cells from bacterial attachment. Vaccine (2004) 0.81

Acetylenic pyridines for use in PET imaging of nicotinic receptors. ChemMedChem (2007) 0.81

A novel method for cerebrospinal fluid diversion: a cadaveric and animal study. Neurosurgery (2011) 0.81

Radiation dosimetry of the translocator protein ligands [18F]PBR111 and [18F]PBR102. Nucl Med Biol (2012) 0.80

A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [(18)F]PBR102 and [(18)F]PBR111, in rat and primate plasma. Nucl Med Biol (2011) 0.79

The observer program: insights from international medical graduates. Educ Health (Abingdon) (2009) 0.79

MISSION Trial - A phase III, multi-center, placebo-controlled trial of sorafenib in patients with relapsed or refractory predominantly non-squamous NSCLC after 2 or 3 previous treatment regimens. J Thorac Oncol (2015) 0.79

Trends in the evolution of the prodynorphin gene in teleosts: cloning of eel and tilapia prodynorphin cDNAs. Peptides (2005) 0.79

Signals from embryonic fibroblasts induce adult intestinal epithelial cells to form nestin-positive cells with proliferation and multilineage differentiation capacity in vitro. Stem Cells (2006) 0.79

Resolving end-of-life ethical concerns: important palliative care practice development issues for acute medicine in Australia. Am J Hosp Palliat Care (2008) 0.78

Rich interpretation vs. deflationary accounts in cognitive development: the case of means-end skills in 7-month-old infants. Cognition (2002) 0.78

Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors. J Med Chem (2008) 0.78

Identification and characterization of KAT, a novel gene preferentially expressed in several human cancer cell lines. Biol Chem (2003) 0.78

Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging). Eur J Nucl Med Mol Imaging (2004) 0.78

Discovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitors. J Med Chem (2015) 0.77

Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine (2004) 0.77

Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples. Invest New Drugs (2013) 0.77

Automated radiosynthesis of [18F]PBR111 and [18F]PBR102 using the Tracerlab FXFN and Tracerlab MXFDG module for imaging the peripheral benzodiazepine receptor with PET. Appl Radiat Isot (2011) 0.77

Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells. Bioorg Med Chem Lett (2009) 0.77

Spinal cord transection for definitive untethering of repetitive tethered cord. Neurosurg Focus (2007) 0.76

Lithium to allow clozapine prescribing in benign ethnic neutropenia. Clin Schizophr Relat Psychoses (2010) 0.76

'All these allied health professionals and you're not really sure when you use them': insights from Australian international medical graduates on working with allied health. Aust Health Rev (2011) 0.76

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors. Cancer Chemother Pharmacol (2010) 0.75

An HIV-1 tat-autoantigen fusion protein suppresses insulitis in NOD mice. Mol Biotechnol (2005) 0.75

Developing a new national approach to surveillance for ventilator-associated events: executive summary. Am J Infect Control (2013) 0.75

Language issues: an important professional practice dimension for Australian International Medical Graduates. Commun Med (2013) 0.75

Correction to Discovery of Potent and Selective 8-Fluorotriazolopyridine c-Met Inhibitors. J Med Chem (2015) 0.75

Plasma biomarkers correlating with clinical outcome in a phase II study of sorafenib in advanced NSCLC. Cancer Biomark (2012) 0.75

"Oh, that's a really hard question": Australian findings on ethical reflection in an accident and emergency ward. HEC Forum (2008) 0.75

Reduction of hERG potassium currents by hyperosmolar solutions. Eur J Pharmacol (2007) 0.75

Point of Care Ultrasound in Family Medicine Residency Programs: A CERA Study. Fam Med (2015) 0.75

International medical graduates' reflections on facilitators and barriers to undertaking the Australian medical council examination. Aust Health Rev (2012) 0.75

Sheep welfare campaign. Vet Rec (2003) 0.75